ICUs are often chaotic environments—where overloaded clinicians, disjointed data systems, and rising burnout converge to threaten patient outcomes. But German medtech startup Clinomic is tackling this crisis head-on with Mona, its AI-powered bedside assistant designed to bring order to the complexity of critical care.
Now, with a fresh €23 million in Series B funding, Clinomic is accelerating its mission to modernise intensive care through artificial intelligence and real-time data solutions.
AI-Powered Mona: A Game-Changer for Intensive Care
At the heart of Clinomic’s innovation is Mona (short for Medical On-Site Assistant), an intelligent bedside system designed to ease the burden on ICU teams. Mona doesn’t just passively display patient data—it actively interprets it. By pulling real-time information from various sources like monitors, labs, and medical records, it helps doctors make faster, better-informed decisions.
Mona listens to voice commands, responds instantly, and even transcribes observations into structured clinical notes. Its voice-activated system reduces the need for physical interaction, cutting documentation time by up to 80% while also lowering the risk of infection.
Beyond documentation, Mona predicts patient deterioration before it becomes critical and connects frontline staff with remote specialists through telemedicine. It’s already been rolled out in over 40 hospitals across eight European countries—and FDA approval is in progress for expansion into the U.S.
Key Takeaways: How Clinomic is Reshaping ICU Care
- Streamlined ICU workflows: Mona automates admin tasks, freeing up clinicians to focus on patient care.
- Real-time insights: AI tools process thousands of patient data points hourly for immediate, actionable alerts.
- Voice-activated and hands-free: Clinicians can interact with Mona during procedures without using a keyboard or screen.
- Global specialist access: Through secure telemedicine, Mona enables real-time expert consultations.
- Predictive analytics: The system flags critical health changes before they escalate.
- Hardware built for ICUs: With a 24″ 4K touchscreen, 8 AI-enabled microphones, and 5G connectivity, Mona fits seamlessly into hospital workflows.
Funding to Expand Global Reach and Product Development
Clinomic’s €23 million Series B round was co-led by Germany’s DeepTech & Climate Fund (DTCF) and a private family office, bringing its total funding to over $50 million. This capital will power international expansion, push Mona into new markets, and strengthen product capabilities with deeper AI and data analytics.
The goal? To become a global standard for smart ICU care.
From ICU Frustration to Innovation
Founded in 2019 by intensive care doctors Arne Peine, Gernot Marx, and Lukas Martin at RWTH Aachen University Hospital, Clinomic was born from real frustration. The team witnessed firsthand how doctors were overwhelmed with nearly 1,000 patient data points per hour—often recorded manually on paper. That struggle inspired Mona.
Starting with minimal resources and relying on public and EU grants, Clinomic has since evolved into a fast-growing medtech company with over 70 experts across engineering, data science, and clinical medicine—all committed to building the future of intensive care.
Why This Matters Now
The COVID-19 pandemic highlighted just how vulnerable healthcare systems are when clinicians are stretched thin and data is poorly managed. Clinomic’s Mona stands out not just as a digital tool—but as a lifeline, especially in overburdened or under-resourced hospitals.
As AI reshapes industries, Clinomic proves it can do more than automate—it can elevate care, support teams, and ultimately, save lives.
